Jim Olson fights cancer with scorpion venom, music and love
Source: The Seattle Times
If you must know — and Dr. Jim Olson sort of wishes you didn’t — the whole idea came during a drunken, post- “Friendsgiving” dinner last year, somewhere around 4 a.m. Olson, a pediatric oncologist at the Fred Hutchinson Cancer Research Center, was drinking whiskey with his friend, musician Noah Gundersen, when they landed on the idea of making a CD of music by local indie artists and selling it to fund Olson’s cancer research. Unlike most ideas hatched this way, it still made sense the next day. So began “The Violet Sessions,” a CD that went on sale last week (projectviolet.org), and includes Gundersen, Hey Marseilles, OK Sweetheart performing in Olson’s home. The CD — and the project — was named after one of Olson’s early patients.
About Seattle Children’s
Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.
Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation's top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.
For more information, visit seattlechildrens.org or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.